TMEM205 and ovarian carcinoma: Recent research has focused on developing nitroxide tethering diarylpiperidone compounds that target TMEM205, demonstrating their ability to reduce exosome secretion and inhibit platinum efflux in platinum-resistant ovarian cancer.